Search hospitals > Florida > Clearwater
Clearwater Cardiovascular Consultants
Claim this profileClearwater, Florida 33756
Conducts research for Heart Failure
Conducts research for Cardiovascular Disease
Conducts research for Coronary Artery Disease
Conducts research for Atherosclerosis
Conducts research for Acute Coronary Syndrome
41 reported clinical trials
5 medical researchers
Summary
Clearwater Cardiovascular Consultants is a medical facility located in Clearwater, Florida. This center is recognized for care of Heart Failure, Cardiovascular Disease, Coronary Artery Disease, Atherosclerosis, Acute Coronary Syndrome and other specialties. Clearwater Cardiovascular Consultants is involved with conducting 41 clinical trials across 64 conditions. There are 5 research doctors associated with this hospital, such as Navas, Douglas Spriggs, MD, Donald Kikta, MD, and Syed Masood Gilani.Top PIs
NavasClearwater Cardiovascular and Interventional Consultants2 years of reported clinical research
Studies Cardiovascular Disease
Studies Atherosclerosis
1 reported clinical trial
2 drugs studied
Douglas Spriggs, MDClearwater Cardiovascular Consultants2 years of reported clinical research
Studies Diabetes
Studies High Blood Pressure
1 reported clinical trial
1 drug studied
Donald Kikta, MDClearwater Cardiovascular Consultants2 years of reported clinical research
Studies Diabetes
Studies High Blood Pressure
1 reported clinical trial
1 drug studied
Syed Masood GilaniClearwater Cardiovascular Consultants3 years of reported clinical research
Studies Coronary Artery Disease
Studies Cardiovascular Disease
2 reported clinical trials
3 drugs studied
Clinical Trials running at Clearwater Cardiovascular Consultants
Heart Failure
Chronic Kidney Disease
Atrial Fibrillation
Diabetes
High Blood Pressure
Kidney Disease
Vascular Disease
Cardiovascular Disease
Inflammation
Systemic Inflammatory Response Syndrome
BI 690517 + Empagliflozin
for Heart Failure
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether BI 690517 in combination with empagliflozin helps people with heart failure. Participants are put into 2 groups by chance. Every participant has an equal chance of being in each group. The groups are: * BI 690517 and empagliflozin group: participants take BI 690517 and empagliflozin as tablets once a day. * Placebo and empagliflozin group: participants take placebo and empagliflozin as tablets once a day. Participants can stay in the study as long as they benefit from treatment and can tolerate it. During this time, they visit their doctors regularly. The doctors regularly check participants' health and take note of any unwanted effects. The study staff may also contact the participants by phone. Participants also regularly answer questions about their well-being. The study does not have a fixed duration. It continues until we have enough data to see if the treatment is working.
Recruiting1 award Phase 32 criteria
Ziltivekimab
for Heart Failure and Inflammation
The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (inactive substance that looks like the study medicine but does not contain any medicine). The treatment participants get is decided by chance. Participant's chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study is expected to last for up to 1 year and 4 months.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clearwater Cardiovascular Consultants?
Clearwater Cardiovascular Consultants is a medical facility located in Clearwater, Florida. This center is recognized for care of Heart Failure, Cardiovascular Disease, Coronary Artery Disease, Atherosclerosis, Acute Coronary Syndrome and other specialties. Clearwater Cardiovascular Consultants is involved with conducting 41 clinical trials across 64 conditions. There are 5 research doctors associated with this hospital, such as Navas, Douglas Spriggs, MD, Donald Kikta, MD, and Syed Masood Gilani.